Suche
Kategorie
Erscheinungsjahr
47541 Treffer
×
Publikationen
×
Johannes Gutenberg-Universität Mainz
×
Hochschule Mainz
×
Hochschule Worms
×
Hochschule Koblenz
- Stein, Alexander; Moehler, Markus; Trojan, Joerg et al.
- Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists
- CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Bd. 130. 2018 S. 13-26
- Alsina, Maria; Moehler, Markus; Lorenzen, Sylvie
- Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies
- ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 266-271
- Weber, Matthias M.; Fottner, Christian
- Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine Neoplasia
- ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 306-312
- Heinrich, Bernd; Czauderna, Carolin; Marquardt, Jens U.
- Immunotherapy of Hepatocellular Carcinoma
- ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 292-297
- Woerns, Marcus-Alexander; Galle, Peter R.
- HEPATOCELLULAR CARCINOMA IN 2017 Two large steps forward, one small step back
- NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. Bd. 15. H. 2. 2018 S. 75-76
- Bowlus, Christopher L.; Neff, Guy W.; Aspinall, Richard et al.
- Efficacy and Safety of Seladelpar, a Selective Peroxisome Proliferator-Activated Receptor Delta Agonist, in Primary Biliary Cholangitis: 52-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 Study
- HEPATOLOGY. Bd. 68. H. 6. 2018 S. 1446A-1447A
- Doria, A.; Stohl, W.; Schwarting, A. et al.
- Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
- ARTHRITIS & RHEUMATOLOGY. Bd. 70. H. 8. 2018 S. 1256-1264
- Bisschops, Raf; Hassan, Cesare; Bhandari, Pradeep et al.
- BASIC (BLI Adenoma Serrated International Classification) classification for colorectal polyp characterization with blue light imaging
- ENDOSCOPY. Bd. 50. H. 3. 2018 S. 211-220
- Castven, D.; Becker, D.; Czauderna, C. et al.
- Application of patient-derived liver cancer cells for personalized treatment approach: from phenotypic characterization to therapeutic target identification
- JOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S683-S683
- Zhu, Andrew X.; Galle, Peter R.; Kudo, Masatoshi et al.
- A study of ramucirumab (LY3009806) versus placebo in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein (REACH-2).
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 4. 2018